Liposomes Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062982
  • May 2021
  • Medical Devices
  • 107 Pages
The Liposomes market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Liposomes market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Johnson and Johnson, Bristol Myers Squibb Company, GlaxoSmithKline Plc, SkyePharma Inc., Serum Institute of India Pvt. Ltd., Gilead Sciences, Inc., Luye Boston R and D IIC, Sun Pharmaceutical Industries Ltd, Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd, CELSION, Inc.,, Abbott, Ipsen Pharma, Spectrum Pharmaceuticals, Inc., Pacira BioSciences, Inc., Takeda Pharmaceutical Company Limited, Astellas Pharma, Inc., Sigma-Tau Group
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Liposomes market along with their effects over the forecast period. Similarly, according to the region Liposomes market research report includes the study of opportunities available in the market situation.

The Liposomes market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Liposomes Market:
The Liposomes market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Johnson and Johnson, Bristol Myers Squibb Company, GlaxoSmithKline Plc, SkyePharma Inc., Serum Institute of India Pvt. Ltd., Gilead Sciences, Inc., Luye Boston R and D IIC, Sun Pharmaceutical Industries Ltd, Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd, CELSION, Inc.,, Abbott, Ipsen Pharma, Spectrum Pharmaceuticals, Inc., Pacira BioSciences, Inc., Takeda Pharmaceutical Company Limited, Astellas Pharma, Inc., Sigma-Tau Group

Liposomes Market Segmentation Analysis:
By Product
Simple Liposomes
Formulated Liposomes
Vaccines
Application
Drug Delivery
Gene Delivery/Transfection
Contrast Agents for Medical Imaging
Model Cell Membranes
Distribution Channel
Retail Sales
Distributional Sales


Global Liposomes Market Segmentation by Regions:
In regional analysis, Liposomes market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Liposomes market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Liposomes Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Liposomes Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Liposomes Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Liposomes Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Liposomes Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Liposomes market, according to the key region.
  • To study the Liposomes market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Liposomes market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Liposomes research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Liposomes market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Liposomes market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Liposomes market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Liposomes market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Liposomes market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Johnson and Johnson
  • Bristol Myers Squibb Company
  • GlaxoSmithKline Plc
  • SkyePharma Inc.
  • Serum Institute of India Pvt. Ltd.
  • Gilead Sciences, Inc.
  • Luye Boston R and D IIC
  • Sun Pharmaceutical Industries Ltd
  • Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd
  • CELSION, Inc.,
  • Abbott
  • Ipsen Pharma
  • Spectrum Pharmaceuticals, Inc.
  • Pacira BioSciences, Inc.
  • Takeda Pharmaceutical Company Limited
  • Astellas Pharma, Inc.
  • Sigma-Tau Group
  • Simple Liposomes
  • Formulated Liposomes
  • Vaccines
  • Retail Sales
  • Distributional Sales

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Liposomes Market Snapshot
          2.1.1. Global Liposomes Market By Product,2019
               2.1.1.1.Simple Liposomes
               2.1.1.2.Formulated Liposomes
               2.1.1.3.Vaccines
          2.1.2. Global Liposomes Market By Distribution Channel,2019
               2.1.2.1.Retail Sales
               2.1.2.2.Distributional Sales
          2.1.3. Global Liposomes Market By End-use,2019
          2.1.4. Global Liposomes Market By Geography,2019

3. Global Liposomes Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Liposomes Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Liposomes Market Size (US$), By Product, 2018 – 2028

5. Global Liposomes Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Liposomes Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Liposomes Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Liposomes Market Size (US$), By End-use, 2018 – 2028

7. Global Liposomes Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Liposomes Market Analysis, 2018 – 2028 
          7.2.1. North America Liposomes Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Liposomes Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Liposomes Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Liposomes Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Liposomes Market Analysis, 2018 – 2028 
          7.3.1.  Europe Liposomes Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Liposomes Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Liposomes Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Liposomes Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Liposomes Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Liposomes Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Liposomes Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Liposomes Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Liposomes Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Liposomes Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Liposomes Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Liposomes Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Liposomes Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Liposomes Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Liposomes Market Analysis, 2018 – 2028 
          7.6.1.  MEA Liposomes Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Liposomes Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Liposomes Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Liposomes Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Liposomes Providers
        8.4.1 Pfizer Inc.
                8.4.1.1 Business Description
                8.4.1.2 Pfizer Inc. Geographic Operations
                8.4.1.3 Pfizer Inc. Financial Information
                8.4.1.4 Pfizer Inc. Product Positions/Portfolio
                8.4.1.5 Pfizer Inc. Key Developments
        8.4.2 Teva Pharmaceutical Industries Ltd.
                8.4.2.1 Business Description
                8.4.2.2 Teva Pharmaceutical Industries Ltd. Geographic Operations
                8.4.2.3 Teva Pharmaceutical Industries Ltd. Financial Information
                8.4.2.4 Teva Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.2.5 Teva Pharmaceutical Industries Ltd. Key Developments
        8.4.3 Novartis AG
                8.4.3.1 Business Description
                8.4.3.2 Novartis AG Geographic Operations
                8.4.3.3 Novartis AG Financial Information
                8.4.3.4 Novartis AG Product Positions/Portfolio
                8.4.3.5 Novartis AG Key Developments
        8.4.4 Johnson and Johnson
                8.4.4.1 Business Description
                8.4.4.2 Johnson and Johnson Geographic Operations
                8.4.4.3 Johnson and Johnson Financial Information
                8.4.4.4 Johnson and Johnson Product Positions/Portfolio
                8.4.4.5 Johnson and Johnson Key Developments
        8.4.5 Bristol Myers Squibb Company
                8.4.5.1 Business Description
                8.4.5.2 Bristol Myers Squibb Company Geographic Operations
                8.4.5.3 Bristol Myers Squibb Company Financial Information
                8.4.5.4 Bristol Myers Squibb Company Product Positions/Portfolio
                8.4.5.5 Bristol Myers Squibb Company Key Developments
        8.4.6 GlaxoSmithKline Plc
                8.4.6.1 Business Description
                8.4.6.2 GlaxoSmithKline Plc Geographic Operations
                8.4.6.3 GlaxoSmithKline Plc Financial Information
                8.4.6.4 GlaxoSmithKline Plc Product Positions/Portfolio
                8.4.6.5 GlaxoSmithKline Plc Key Developments
        8.4.7 SkyePharma Inc.
                8.4.7.1 Business Description
                8.4.7.2 SkyePharma Inc. Geographic Operations
                8.4.7.3 SkyePharma Inc. Financial Information
                8.4.7.4 SkyePharma Inc. Product Positions/Portfolio
                8.4.7.5 SkyePharma Inc. Key Developments
        8.4.8 Serum Institute of India Pvt. Ltd.
                8.4.8.1 Business Description
                8.4.8.2 Serum Institute of India Pvt. Ltd. Geographic Operations
                8.4.8.3 Serum Institute of India Pvt. Ltd. Financial Information
                8.4.8.4 Serum Institute of India Pvt. Ltd. Product Positions/Portfolio
                8.4.8.5 Serum Institute of India Pvt. Ltd. Key Developments
        8.4.9 Gilead Sciences, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Gilead Sciences, Inc. Geographic Operations
                8.4.9.3 Gilead Sciences, Inc. Financial Information
                8.4.9.4 Gilead Sciences, Inc. Product Positions/Portfolio
                8.4.9.5 Gilead Sciences, Inc. Key Developments
        8.4.10 Luye Boston R and D IIC
                8.4.10.1 Business Description
                8.4.10.2 Luye Boston R and D IIC Geographic Operations
                8.4.10.3 Luye Boston R and D IIC Financial Information
                8.4.10.4 Luye Boston R and D IIC Product Positions/Portfolio
                8.4.10.5 Luye Boston R and D IIC Key Developments
        8.4.11 Sun Pharmaceutical Industries Ltd
                8.4.11.1 Business Description
                8.4.11.2 Sun Pharmaceutical Industries Ltd Geographic Operations
                8.4.11.3 Sun Pharmaceutical Industries Ltd Financial Information
                8.4.11.4 Sun Pharmaceutical Industries Ltd Product Positions/Portfolio
                8.4.11.5 Sun Pharmaceutical Industries Ltd Key Developments
        8.4.12 Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd
                8.4.12.1 Business Description
                8.4.12.2 Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd Geographic Operations
                8.4.12.3 Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd Financial Information
                8.4.12.4 Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd Product Positions/Portfolio
                8.4.12.5 Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd Key Developments
        8.4.13 CELSION, Inc.,
                8.4.13.1 Business Description
                8.4.13.2 CELSION, Inc., Geographic Operations
                8.4.13.3 CELSION, Inc., Financial Information
                8.4.13.4 CELSION, Inc., Product Positions/Portfolio
                8.4.13.5 CELSION, Inc., Key Developments
        8.4.14 Abbott
                8.4.14.1 Business Description
                8.4.14.2 Abbott Geographic Operations
                8.4.14.3 Abbott Financial Information
                8.4.14.4 Abbott Product Positions/Portfolio
                8.4.14.5 Abbott Key Developments
        8.4.15 Ipsen Pharma
                8.4.15.1 Business Description
                8.4.15.2 Ipsen Pharma Geographic Operations
                8.4.15.3 Ipsen Pharma Financial Information
                8.4.15.4 Ipsen Pharma Product Positions/Portfolio
                8.4.15.5 Ipsen Pharma Key Developments
        8.4.16 Spectrum Pharmaceuticals, Inc.
                8.4.16.1 Business Description
                8.4.16.2 Spectrum Pharmaceuticals, Inc. Geographic Operations
                8.4.16.3 Spectrum Pharmaceuticals, Inc. Financial Information
                8.4.16.4 Spectrum Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.16.5 Spectrum Pharmaceuticals, Inc. Key Developments
        8.4.17 Pacira BioSciences, Inc.
                8.4.17.1 Business Description
                8.4.17.2 Pacira BioSciences, Inc. Geographic Operations
                8.4.17.3 Pacira BioSciences, Inc. Financial Information
                8.4.17.4 Pacira BioSciences, Inc. Product Positions/Portfolio
                8.4.17.5 Pacira BioSciences, Inc. Key Developments
        8.4.18 Takeda Pharmaceutical Company Limited
                8.4.18.1 Business Description
                8.4.18.2 Takeda Pharmaceutical Company Limited Geographic Operations
                8.4.18.3 Takeda Pharmaceutical Company Limited Financial Information
                8.4.18.4 Takeda Pharmaceutical Company Limited Product Positions/Portfolio
                8.4.18.5 Takeda Pharmaceutical Company Limited Key Developments
        8.4.19 Astellas Pharma, Inc.
                8.4.19.1 Business Description
                8.4.19.2 Astellas Pharma, Inc. Geographic Operations
                8.4.19.3 Astellas Pharma, Inc. Financial Information
                8.4.19.4 Astellas Pharma, Inc. Product Positions/Portfolio
                8.4.19.5 Astellas Pharma, Inc. Key Developments
        8.4.20 Sigma-Tau Group
                8.4.20.1 Business Description
                8.4.20.2 Sigma-Tau Group Geographic Operations
                8.4.20.3 Sigma-Tau Group Financial Information
                8.4.20.4 Sigma-Tau Group Product Positions/Portfolio
                8.4.20.5 Sigma-Tau Group Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Liposomes Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Liposomes Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Liposomes Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Liposomes Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Liposomes Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Liposomes Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Liposomes Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Liposomes Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Liposomes Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Liposomes Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Liposomes Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Liposomes Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Liposomes Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Liposomes Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Liposomes Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Liposomes Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Liposomes: Market Segmentation 
FIG. 2 Global Liposomes Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Liposomes Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Liposomes Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Liposomes Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Liposomes Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Liposomes Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Liposomes Providers, 2019
FIG. 11 Global Liposomes Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Liposomes Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Liposomes Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Liposomes Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Liposomes Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Liposomes Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Liposomes Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Liposomes Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Liposomes market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Liposomes Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Liposomes Market Value, By Segment1, 2018 – 2028
TABLE  North America Liposomes Market Value, By Segment2, 2018 – 2028
TABLE  North America Liposomes Market Value, By Country, 2018 – 2028
TABLE  Europe Liposomes Market Value, By Segment1, 2018 – 2028
TABLE  Europe Liposomes Market Value, By Segment2, 2018 – 2028
TABLE  Europe Liposomes Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Liposomes Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Liposomes Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Liposomes Market Value, By Country, 2018 – 2028
TABLE  Latin America Liposomes Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Liposomes Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Liposomes Market Value, By Country, 2018 – 2028
TABLE  MEA Liposomes Market Value, By Segment1, 2018 – 2028
TABLE  MEA Liposomes Market Value, By Segment2, 2018 – 2028
TABLE  MEA Liposomes Market Value, By Country, 2018 – 2028
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson and Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  SkyePharma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Serum Institute of India Pvt. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead Sciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Luye Boston R and D IIC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sun Pharmaceutical Industries Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CELSION, Inc.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ipsen Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Spectrum Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pacira BioSciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceutical Company Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Astellas Pharma, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sigma-Tau Group: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Liposomes Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Liposomes Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Liposomes Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Liposomes Market, By Geography, 2019 (US$ Mn)
FIG.  Global Liposomes Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Liposomes Providers, 2016
FIG.  Global Liposomes Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Formulated Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Liposomes Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Distributional Sales Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Liposomes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Liposomes Market Value, 2018 – 2028, (US$ Mn)